Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan's in vitro diagnostics (IVD) market - more automation, more probes

This article was originally published in Clinica

Executive Summary

This article is based on a report produced by Brussels-based management consultancy Glover Leonard & Redshaw, which last year carried out extensive research on the Japanese in vitro diagnostic market. Clinical diagnostic testing in Japan is performed both by commercial and hospital laboratories. The commercial sector comprises some 850 labs, of which 400 have fewer than 10 employees and 350 have 10-49 employees. Around 35% of total commercial laboratory turnover - estimated at ¥50,000 million ($6,500 million) - is represented by the 12 largest labs (more than 200 employees), led by SRL, which has 10 subsidiaries and annual sales of some Yen57,000 million.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT087760

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel